We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
Ai Zheng = Aizheng = Chinese Journal of Cancer 2007 January
BACKGROUND & OBJECTIVE: Cyclooxygenase-2 (COX-2) protein is highly expressed in hepatocellular carcinoma (HCC). It may be involved in tumorigenesis and development of HCC. This study was to explore the effects of COX-2 short hairpin RNA (shRNA) on COX-2 expression in HCC cell line HepG2 and on adhesiveness and invasiveness of HepG2 cells in vitro.
METHODS: Plasmids WBH1 and WBH2 containing 2 different sequences of human COX-2 mRNA coding region were constructed, and transfected into HepG2 cells, respectively. The expression of COX-2 was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot at 24, 48, 72 and 96 h after transfection. At 48 h after transfection, the adhesiveness of HepG2 cells to extracellular matrix matrigel was detected using MTT assay. Invasiveness was measured by Transwell experiment.
RESULTS: The transfection rate in HepG2 cells was about 60%. The inhibition rates of COX-2 mRNA expression in HepG2 cells were 18.5%, 88.6%, 52.8%, and 42.4% at 24, 48, 72 and 96 h after transfection of plasmid WBH1 (P<0.01); the inhibition rates of COX-2 protein expression were 10.2%, 80.5%, 45.3%, and 39.0%, respectively (P<0.01). Plasmid WBH2 had no significant inhibitory effect on COX-2 expression in HepG2 cells (P>0.05). The adhesion rate of WBH1-transfected cells was obviously reduced by 47.4% of control cells [(6.0+/-0.4)% vs. (11.4+/-0.2)%, P<0.01]. The cell number that infiltrated Transwell membrane in WBH1-transfected group was significantly reduced by 63.7% of control group (8.25+/-1.50 vs. 22.75+/-1.70, P<0.01). WBH2 had no obvious effects on adhesiveness and invasiveness of HepG2 cells.
CONCLUSION: COX-2 shRNA can inhibit the adhesiveness and invasiveness of HepG2 cells through intervening the expression of COX-2.
METHODS: Plasmids WBH1 and WBH2 containing 2 different sequences of human COX-2 mRNA coding region were constructed, and transfected into HepG2 cells, respectively. The expression of COX-2 was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot at 24, 48, 72 and 96 h after transfection. At 48 h after transfection, the adhesiveness of HepG2 cells to extracellular matrix matrigel was detected using MTT assay. Invasiveness was measured by Transwell experiment.
RESULTS: The transfection rate in HepG2 cells was about 60%. The inhibition rates of COX-2 mRNA expression in HepG2 cells were 18.5%, 88.6%, 52.8%, and 42.4% at 24, 48, 72 and 96 h after transfection of plasmid WBH1 (P<0.01); the inhibition rates of COX-2 protein expression were 10.2%, 80.5%, 45.3%, and 39.0%, respectively (P<0.01). Plasmid WBH2 had no significant inhibitory effect on COX-2 expression in HepG2 cells (P>0.05). The adhesion rate of WBH1-transfected cells was obviously reduced by 47.4% of control cells [(6.0+/-0.4)% vs. (11.4+/-0.2)%, P<0.01]. The cell number that infiltrated Transwell membrane in WBH1-transfected group was significantly reduced by 63.7% of control group (8.25+/-1.50 vs. 22.75+/-1.70, P<0.01). WBH2 had no obvious effects on adhesiveness and invasiveness of HepG2 cells.
CONCLUSION: COX-2 shRNA can inhibit the adhesiveness and invasiveness of HepG2 cells through intervening the expression of COX-2.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app